Response to first-line treatment
| Treatment . | n . | Response rate to first-line therapy, n/N (%) . | Treatment interruption . | ||
|---|---|---|---|---|---|
| ORR . | CR . | N/A . | Toxicity . | ||
| MTX | 34 | 7/26 (26.9) | 2/26 (7.7) | 4 | 4 |
| CyA | 15 | 7/13 (53.9) | 3/13 (23.1) | 2 | — |
| CTX | 6 | 2/5 (40) | 2/5 (40) | 1 | — |
| Cladribine | 1 | 1/1 (100) | 0/1 (0) | — | — |
| Splenectomy | 1 | 0/1 (0) | 0/1 (0) | — | — |
| Treatment . | n . | Response rate to first-line therapy, n/N (%) . | Treatment interruption . | ||
|---|---|---|---|---|---|
| ORR . | CR . | N/A . | Toxicity . | ||
| MTX | 34 | 7/26 (26.9) | 2/26 (7.7) | 4 | 4 |
| CyA | 15 | 7/13 (53.9) | 3/13 (23.1) | 2 | — |
| CTX | 6 | 2/5 (40) | 2/5 (40) | 1 | — |
| Cladribine | 1 | 1/1 (100) | 0/1 (0) | — | — |
| Splenectomy | 1 | 0/1 (0) | 0/1 (0) | — | — |
N/A, not available.